Contact details

Type of addressPostal address
Postal codeYO10 5DD
CountryUnited Kingdom
Address lines
  • Centre for Health Economics
    University of York
    Heslington
    York
    YO10 5DD

Phone: (01904) 321434

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations

Prof. Stephen John Palmer

Professor

  1. 2014
  2. 2013
  3. 2012
  4. Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions

    Walker, S. M., Sculpher, M., Claxton, K. P. & Palmer, S. J., Apr 2012, York UK: Centre for Health Economics, University of York. 40 p. (CHE Research Paper; no. 77)

    Research output: Book/ReportOther report

  5. Appropriate perspectives for health care decisions

    Walker, S. M., Griffin, S., Claxton, K. P., Palmer, S. J. & Sculpher, M., 2012, Unit costs of health and social care 2012. Canterbury: PSSRU University of Kent

    Research output: Chapter in Book/Report/Conference proceedingChapter

  6. 2011
  7. Uncertainty, evidence and irrecoverable costs: informing approval, pricing and research decisions for health technologies

    Claxton, K. P., Palmer, S. J., Longworth, L., Bojke, L., Griffin, S., McKenna, C., Soares, M. O., Spackman, E. & Youn, J., Oct 2011, York, UK: Centre for Health Economics, University of York, 81 p. (CHE Research Paper; no. 69).

    Research output: Working paper

  8. Fingolimod for the treatment of relapsing remitting multiple sclerosis

    CRD and CHE Technology Assessment Group, Asaria, M., Norman, G., Hinde, S., O'Connor, J., Palmer, S. J., Light, K., O Soares, M. & Eastwood, A. J., Jun 2011, Centre for Reviews and Dissemination/ Centre for Health Economics.

    Research output: Book/ReportCommissioned report

  9. 2010
  10. Evaluating the Quality of Research into a Single Prognostic Biomarker: A Systematic Review and Meta-analysis of 83 Studies of C-Reactive Protein in Stable Coronary Artery Disease

    Hemingway, H., Philipson, P., Chen, R., Fitzpatrick, N. K., Damant, J., Shipley, M., Abrams, K. R., Moreno, S., McAllister, K. S. L., Palmer, S., Kaski, J. C., Timmis, A. D. & Hingorani, A. D., Jun 2010

    Literature review in Plos medicine

  11. Primary angioplasty versus thrombolysis for acute ST-elevation myocardial infarction: an economic analysis of the National Infarct Angioplasty project

    Wailoo, A., Goodacre, S., Sampson, F., Alava, M. H., Asseburg, C., Palmer, S., Sculpher, M., Abrams, K., de Belder, M. & Gray, H., May 2010

    Article in Heart

  12. Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction

    CRD and CHE Technology Assessment Group, Norman, G., Rice, S. J., Spackman, E., Stirk, L., Danso-Appiah, T., Suh, D., Palmer, S. J. & Eastwood, A. J., May 2010, Centre for Reviews and Dissemination/ Centre for Health Economics.

    Research output: Book/ReportCommissioned report

  13. The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model

    Hemingway, H., Henriksson, M., Chen, R., Damant, J., Fitzpatrick, N., Abrams, K., Hingorani, A., Janzon, M., Shipley, M., Feder, G., Keogh, B., Stenestrand, U., McAllister, K., Kaski, J-C., Timmis, A., Palmer, S. & Sculpher, M., Feb 2010

    Article in Health technology assessment

  14. Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgery

    Henriksson, M., Palmer, S., Chen, R., Damant, J., Fitzpatrick, N. K., Abrams, K., Hingorani, A. D., Stenestrand, U., Janzon, M., Feder, G., Keogh, B., Shipley, M. J., Kaski, J-C., Timmis, A., Sculpher, M. & Hemingway, H., 19 Jan 2010

    Article in British medical journal

  15. Appropriate perspectives for health care decisions.

    Claxton, K., Palmer, S., Sculpher, M. & Walker, S., 2010, York, UK: Centre for Health Economics, University of York, 86 p. (CHE Research Paper; no. 54).

    Research output: Working paperDiscussion paper

  16. 2009
  17. Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation.

    Burch, J., Paulden, M., Conti, S., Stock, C., Corbett, M., Welton, N. J., Ades, A. E., Sutton, A., Cooper, N., Elliot, A. J., Nicholson, K., Duffy, S., McKenna, C., Stewart, L., Westwood, M. & Palmer, S., Nov 2009

    Article in Health technology assessment

  18. Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia

    Walker, S., Palmer, S., Erhorn, S., Brent, S., Dyker, A., Ferrie, L., Horsley, W., Macfarlane, S., White, S. & Thomas, S., Jun 2009

    Article in Health technology assessment

  19. Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix

    CRD and CHE Technology Assessment Group, Paton, F. C. W., Paulden, M., Saramago, P., Manca, A., Misso, K., Palmer, S. J. & Eastwood, A. J., Apr 2009, Centre for Reviews and Dissemination/ Centre for Health Economics.

    Research output: Book/ReportCommissioned report

  20. The use of paclitaxel in the management of early stage breast cancer.

    Griffin, S., Dunn, G., Palmer, S., Macfarlane, S., Brent, S., Dyker, A., Erhorn, A., Humphries, C., White, S., Horsley, W., Ferrie, L. & Thomas, S., 2009.

    Research output: Working paper

  21. 2008
  22. The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial

    Henriksson, M., Epstein, D. M., Palmer, S. J., Sculpher, M. J., Clayton, T. C., Pocock, S. J., Henderson, R. A., Buxton, M. J. & Fox, K. A. A., Jun 2008

    Article in Heart

  23. Modelling strategies to address childhood overweight and obesity in the UK: An exploratory cost-utility analysis

    Nixon, J., Fayter, D., Hartley, S., Rithalia, A., Stirk, L., Westwood, M., Palmer, S., Rudolf, M., Glasziou, P., Bland, M. & Butler, G., 2008

    Article in Hormone research

  24. 2007